» Authors » Caroline M Hsu

Caroline M Hsu

Explore the profile of Caroline M Hsu including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 23
Citations 341
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Hsu C, Lacson E, Manley H, Aweh G, Miskulin D, Johnson D, et al.
Am J Kidney Dis . 2022 Apr; 80(1):151-153. PMID: 35378208
No abstract available.
12.
Manley H, Lacson Jr E, Aweh G, Li N, Weiner D, Miskulin D, et al.
Am J Kidney Dis . 2022 Mar; 80(3):309-318. PMID: 35288216
Rationale & Objective: High-dose influenza vaccine provides better protection against influenza infection in older adults than standard-dose vaccine. We compared vaccine seroresponse among hemodialysis patients over a period of 4...
13.
Hsu C, Weiner D, Manley H, Aweh G, Ladik V, Frament J, et al.
Clin J Am Soc Nephrol . 2022 Feb; 17(3):403-413. PMID: 35144972
Background And Objectives: Although most patients receiving maintenance dialysis exhibit initial seroresponse to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination, concerns exist regarding the durability of this antibody response....
14.
Hsu C, Gupta S, Tighiouart H, Goyal N, Faugno A, Tariq A, et al.
Am J Kidney Dis . 2021 Dec; 79(3):404-416.e1. PMID: 34871701
Rationale & Objective: Acute kidney injury treated with kidney replacement therapy (AKI-KRT) occurs frequently in critically ill patients with coronavirus disease 2019 (COVID-19). We examined the clinical factors that determine...
15.
Hsu C, Weiner D, Aweh G, Manley H, Ladik V, Frament J, et al.
Am J Kidney Dis . 2021 Nov; 79(2):307-310. PMID: 34758369
No abstract available.
16.
Lacson Jr E, Argyropoulos C, Manley H, Aweh G, Chin A, Salman L, et al.
J Am Soc Nephrol . 2021 Aug; 32(11):2735-2742. PMID: 34348908
Background: Patients receiving maintenance dialysis represent a high-risk, immune-compromised population with 15%-25% COVID-19 mortality rate who were unrepresented in clinical trials of mRNA vaccines. Methods: All patients receiving maintenance dialysis...
17.
Hsu C, Weiner D, Aweh G, Salenger P, Johnson D, Lacson Jr E
J Am Soc Nephrol . 2021 Jun; 32(7):1569-1573. PMID: 34108232
No abstract available.
18.
Lacson E, Argyropoulos C, Manley H, Aweh G, Chin A, Salman L, et al.
medRxiv . 2021 Apr; PMID: 33880482
Background: Patients receiving maintenance dialysis represent a high risk, immune-compromised population with 15-25% COVID mortality rate who were unrepresented in clinical trials evaluated for mRNA vaccines' emergency use authorization. Method:...
19.
Hsu C, Murad H, Neuendorf K, Gao T, Schold J, Saeed F
Clin Nephrol . 2021 Apr; 96(1):22-28. PMID: 33835012
Background: The majority of dialysis patients receive aggressive burdensome treatment near the end of life. Currently, we lack interventions to improve end-of-life care (EoLC) for these patients. We examined the...
20.
Hsu C, Weiner D, Aweh G, Miskulin D, Manley H, Stewart C, et al.
Am J Kidney Dis . 2021 Jan; 77(5):748-756.e1. PMID: 33465417
Rationale & Objective: During the coronavirus disease 2019 (COVID-19) pandemic, patients receiving maintenance dialysis are a highly vulnerable population due to their comorbidities and circumstances that limit physical distancing during...